Related Experiment Videos
Bronchodilators and diuretics in children with bronchopulmonary dysplasia
Insights
Furosemide and atropine improved lung function in infants with bronchopulmonary dysplasia (BPD). These medications increased dynamic compliance, offering potential benefits for managing BPD-related respiratory issues.
Area of Science:
- Pediatric Pulmonology
- Neonatology
- Respiratory Medicine
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease in infants.
- Infants with BPD often experience small airway dysfunction.
- Pulmonary edema and increased vagal tone may contribute to BPD complications.
Purpose of the Study:
- To assess the effects of furosemide, isoproterenol, and atropine on pulmonary function in infants with BPD.
- To evaluate potential therapeutic interventions for small airway dysfunction in BPD.
Main Methods:
- A self-controlled study involving six infants (5-43 months) with moderate to severe BPD.
- Pulmonary function tests (PFT) were conducted after administering IV furosemide, inhaled isoproterenol, inhaled atropine sulfate, and placebo.
- Measurements included dynamic compliance (CL), total pulmonary resistance (RL), and work of breathing (W).
Main Results:
- Furosemide and atropine significantly increased dynamic compliance (CL) in the study group (P < 0.05).
- Isoproterenol showed a trend towards decreasing total pulmonary resistance (RL) and work of breathing (W), though not statistically significant (P = 0.08, P = 0.09).
Conclusions:
- Intravenous furosemide and inhaled atropine sulfate demonstrate efficacy in improving dynamic lung compliance in infants with BPD.
- These findings suggest that pulmonary edema and vagal tone may play roles in small airway dysfunction in BPD.
- Further research is warranted to explore these therapeutic strategies for BPD management.
Abstract:
Pulmonary function tests (PFT) were obtained during the course of a self-controlled study of six children aged 5 to 43 months who had moderate to severe bronchopulmonary dysplasia (BPD). Changes after the administration of intravenous (IV) furosemide (2 mg/kg), inhaled isoproterenol (0.2 cc, 1:200), inhaled atropine sulfate (0.05 mg/kg), and a placebo were assessed. The study indicated the furosemide and atropine significantly (P less than 0.05) increased dynamic compliance (CL) for the group. A decrease in total pulmonary resistance (RL) and work of breathing (W) was observed after isoproterenol, although the responses were not significant (P = 0.08 and P = 0.09, respectively). It was speculated that pulmonary edema and increased vagal tone may contribute to small airway dysfunction in children who have BPD.